Good morning :)
Switch to
Place Order

Nectar Lifesciences Ltd

NECLIFE
Health CarePharmaceuticals
SmallcapWith a market cap of ₹512 cr, stock is ranked 1,323
High RiskStock is 3.01x as volatile as Nifty
22.451.75% (-0.40)
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
SmallcapWith a market cap of ₹512 cr, stock is ranked 1,323
High RiskStock is 3.01x as volatile as Nifty

Key Metrics

PE RatioPE RatioPB RatioPB RatioDividend YieldDiv. Yield
20.460.47
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
35.644.360.89%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Nectar Lifesciences Limited is a pharmaceutical company. The Company's operations include manufacturing and marketing of oral and sterile cephalosporin's, phytochemicals and allied products.

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Financial TrendFinancial statements 

2019202020212022+2.79+2.37+1.55+1.68+0.05+0.03-0.07+0.03
Revenue
Profit
Loss
All values in ₹ Thousand cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

High Pledged Promoter Holding
Lower pledged promoter holdings is considered better

A significant proportion of promoter holdings is pledged

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent NewsAll news 

Hmm, looks like data is unavailable here. Please come back after some time
See all news

Recent EventsAll events 

Related Party Transaction 
Announced OnNov 21, 2022

Nectar Lifesciences Limited has informed the Exchange about related party transaction for the period ended September 2022 | Download

Nectar Lifesciences Limited has informed the Exchange about related party transaction for the period ended September 2022 | Download

Newspaper Advertisements 
Announced OnNov 18, 2022

Nectar Lifesciences Limited has informed the Exchange about Newspaper Advertisements in respect of informing about dispatch/ mailing of Postal Ballot Notice and E-voting, which have been published in the following newspapers:1. Business Standard (English-all editions) dated 18.11.20222. Desh Sewak (Punjabi) dated 18.11.2022 | Download

Nectar Lifesciences Limited has informed the Exchange about Newspaper Advertisements in respect of informing about dispatch/ mailing of Postal Ballot Notice and E-voting, which have been published in the following newspapers:1. Business Standard (English-all editions) dated 18.11.20222. Desh Sewak (Punjabi) dated 18.11.2022 | Download

Cash Dividend 
Ex. DateSep 11, 2020

Final • Div/Share: ₹ 0.05

See all events